期刊文献+

拜新同与北京降压0号或海捷亚合用治疗老年性单纯性收缩期高血压疗效观察 被引量:4

Efficacy of nifedipine controlled release tablets in combination with hypotensive tablets or losartan potassium and hydrochlorothiazide on elderly patients with isolated systolic hypertension
暂未订购
导出
摘要 目的:观察和分析拜新同分别联合北京降压0号或海捷亚治疗老年性单纯性收缩期高血压(ISH)的疗效及对代谢的影响。方法:选择83例老年ISH患者随机分为3组,拜新同组(A组,n=28,拜新同30mg,1次/d),拜新同与北京降压0号合用组(B组,n=28,拜新同30mg,1次/d,北京降压0号1片,1次/d),拜新同与海捷亚合用组(C组,n=27,拜新同30mg,1次/d,海捷亚50mg,1次/d)。3组治疗疗程均为12周,观察3组治疗前后的血压及肝肾功能、血糖、血脂、电解质等指标的变化。结果:B、C组降压总有效率相当,其对随测血压、24h动态血压的控制疗效接近;B、C组血压控制效果明显优于A组;3组治疗前后心率及生化指标无明显改变。结论:拜新同与北京降压0号或海捷亚合用降低老年ISH均有较显著且相似的疗效,与单用拜新同比较效果更好。 Objective To study the efficacy of nifedipine controlled release tablets (NCRT) in combination with hypotensive tablets or losartan potassium and hydrochlorothiazide (HYZAAR) on elderly patients with isolated systolic hypertension (ISH), and the influence on metabolism. Methods Eighty three elderly patients were ramdomly divided into three groups, Group A(n=28) : NCRT alone(30 mg qd),Group B(n:28):NCRT(30 mg qd) plus hypotensive tablets( 1 tablet qd),Group C (n=27): NCRT (30 mg qd)plus HYZAAR (50 mg qd). They were all treated for 12 weeks. The changes of blood pressure, liner function indicator, renal function indicator, blood glucose, blood fat, plasm electrolytes were observed. Results The depressurization effect and efficacy on random tested blood pressure and 24 h ambulatory blood pressure of Group B and C were resemble, and were better than Group A. There were on significant changes of heart rate, biochemical indicator between before and after treatment in the three groups. Conclusion There are remarkably effects of NCRT combined with hypotensive tablets or losartan potassium and hydrochlorothiazide on elderly patients with ISH,and the efficacy between the two groups is resemble, and is not only better than Group A,but also doesn't obviously affect the metabolism.
作者 肖明生 黄勇
机构地区 解放军第
出处 《实用医学杂志》 CAS 2007年第7期1039-1042,共4页 The Journal of Practical Medicine
关键词 高血压 硝苯地平 洛沙坦 Hypertension Nifedipine Losartan
  • 相关文献

参考文献6

二级参考文献9

  • 1吴文源 张明圆.症状自评量表.精神科量表手册[M].长沙:湖南科学技术出版社,1998.16-27.
  • 2李家泰.临床药理学(第二版)[M].北京:人民卫生出版社,1998.818.
  • 3Neaton JD,Grimm RU J,Prineas RJ,et al. Treatment of Mild Hypertension Study. Final results. Treatment of Mild Hypertension Study Research Group [J]. JAMA,1993,270.713-715.
  • 4Daholof B, Keller SE, Makris L, et al. Efficacy end safety of losaran compared with hydoehlorothiazide in patients with mild to severe hypertension [J ]. Am J Hypertens,1994,7: 37-39.
  • 5Veliviot M, Dai XC, Goldberg AI, et al. Safety and efficacy of lo~,artan potassium/hydmhlorothiazide combination tablet in patients with severe hypertension[J]. Am J Hypertens , 1995,8 : 192-194.
  • 6Weber MA,Byyny RL, Prat JH, et al. Blood pressure effects of the angiotensin receptor bloker losartan[J ]. Arch Intern Med, 1995,155 : 405-407.
  • 7Johnson GD. Selecting appropriate antihypertensive drug dosage[ J ]. Drug, 1994,47:567-569.
  • 8Sajka C, Buclin T, Brunner HR, et al. Pharmacokinetic pharmadynarnic profile of angiotensin receptor antagonists[J ]. Clin Pharmaeokinetics, 1997,32:1-4.
  • 9Kaplan NM, Gifford RWJ. Choice of initial therapy for hypertension[ J ]. JAMA, 1996,275 : 1577-1579.

共引文献2655

同被引文献53

引证文献4

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部